Paul Sperduto, MD, MPP, named fellow of prestigious cancer organization

Waconia, MN (July 9, 2014)—The American Society for Radiation Oncology (ASTRO) has selected 30 distinguished members to receive the Fellow of ASTRO designation (FASTRO). Paul W. Sperduto, MD, MPP, Minneapolis Radiation Oncology, director of Radiation Oncology at Ridgeview Medical Center in Waconia and co-director of the Gamma Knife Center at the University of Minnesota, will receive his FASTRO designation during the awards ceremony on Sept. 16 at ASTRO’s 56th Annual Meeting, in San Francisco.

“Dr. Sperduto joins an elite group of ASTRO members who have significantly contributed to the Society, the specialty and cancer patients worldwide through their service to ASTRO and leadership in research, education and patient care,” said ASTRO President Bruce G. Haffty, MD, FASTRO, professor and chair of the Department of Radiation Oncology at Rutgers–Robert Wood Johnson Medical School and associate director of the Rutgers Cancer Institute of New Jersey. “Congratulations to Dr. Sperduto on achieving the designation of ASTRO Fellow.”

Awarded annually since 2006, the Fellows Program honors those who have been a member of ASTRO for at least 15 years, who have contributed the equivalent of 10 years of service to ASTRO and who have made substantial contributions to the field of radiation oncology in the areas of research, education, patient care or service and leadership. Including the 2014 class of Fellows, 242 of ASTRO’s more than 10,000 members worldwide have received the FASTRO designation.

Candidates are nominated by a current ASTRO Fellow and supported by three additional ASTRO members. A 10-member Fellows Selection Committee reviewed the nominations and presented the slate of recommended Fellows to ASTRO’s Board of Directors for final approval.

Dr. Sperduto has three degrees from Duke University (BA, MD, MPP) and completed his radiation oncology training at the National Cancer Institute. Before joining Minneapolis Radiation Oncology, he served on the faculty at the University of Minnesota.

He has been principal investigator on three international clinical trials on the management of brain tumors, and has published more than 55 articles in peer-reviewed medical journals and five book chapters.

Some of his many awards include the Henry Luce Scholarship given to 15 “future leaders of America”; the Jones and Guerrero Research Scholarship, given by the Duke School of Medicine; the Lane Adams Award, given by the American Cancer Society for excellence in promoting quality of life in cancer patients; and the Society of Neuro-Oncology (SNO) Award for Excellence in Clinical Research, given for brain tumor research deemed most important by SNO.

He has been the plenary speaker at the ASTRO annual meeting, a visiting professor in China, a Humphrey Fellow at the Humphrey Institute of Public Affairs, an advisor to the Pentagon on the Medical Free Electron Laser Program, president of the X-Knife Society (a worldwide consortium of more than 250 institutions using stereotactic radiosurgery for brain tumors), a frequent invited speaker at research meetings across the United States and abroad, and now serves as co-editor of the textbook, Treatment Planning in Radiation Oncology. He designed a prognostic index that is now widely used to estimate survival for patients with brain tumors. He has provided cyclone relief in India and primary care in Appalachia.

Dr. Sperduto maintains a busy clinical practice as co-director of the Gamma Knife Center at the University of Minnesota and as director of Radiation Oncology at Ridgeview Medical Center, where he has also served as president of the medical staff and Cancer Liaison Physician for the American Cancer Society. He has been repeatedly recognized as a “Top Doc” by Minneapolis/St. Paul magazine. For more information about Dr. Sperduto, visit


ASTRO is the premier radiation oncology society in the world, with more than 10,000 members who are physicians, nurses, biologists, physicists, radiation therapists, dosimetrists and other health care professionals that specialize in treating patients with radiation therapies. As the leading organization in radiation oncology, the Society is dedicated to improving patient care through professional education and training, support for clinical practice and health policy standards, advancement of science and research, and advocacy. ASTRO publishes two medical journals, International Journal of Radiation Oncology * Biology * Physics ( and Practical Radiation Oncology (; developed and maintains an extensive patient website,; and created the Radiation Oncology Institute (, a nonprofit foundation to support research and education efforts around the world that enhance and confirm the critical role of radiation therapy in improving cancer treatment. To learn more about ASTRO, visit